Transcriptional networks implicated in human nonalcoholic fatty liver disease

被引:0
|
作者
Hua Ye
Wei Liu
机构
[1] Ningbo Medical Treatment Center Lihuili Hospital,Department of Gastroenterology
[2] Fujian Agriculture and Forestry University,School of Life Sciences
[3] Human Centrifuge Medical Training Center,Department of Pathology
[4] Institute of Aviation Medicine of Chinese PLA Air Force,undefined
来源
关键词
Nonalcoholic fatty liver disease; Transcriptome; Gene co-expression network; Hub gene; microRNA;
D O I
暂无
中图分类号
学科分类号
摘要
The transcriptome of nonalcoholic fatty liver disease (NAFLD) was investigated in several studies. However, the implications of transcriptional networks in progressive NAFLD are not clear and mechanisms inducing transition from nonalcoholic simple fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) are still elusive. The aims of this study were to (1) construct networks for progressive NAFLD, (2) identify hub genes and functional modules in these networks and (3) infer potential linkages among hub genes, transcription factors and microRNAs (miRNA) for NAFLD progression. A systems biology approach by combining differential expression analysis and weighted gene co-expression network analysis (WGCNA) was utilized to dissect transcriptional profiles in 19 normal, 10 NAFL and 16 NASH patients. Based on this framework, 3 modules related to chromosome organization, proteasomal ubiquitin-dependent protein degradation and immune response were identified in NASH network. Furthermore, 9 modules of co-expressed genes associated with NAFL/NASH transition were found. Further characterization of these modules defined 13 highly connected hub genes in NAFLD progression network. Interestingly, 11 significantly changed miRNAs were predicted to target 10 of the 13 hub genes. Characterization of modules and hub genes that may be regulated by miRNAs could facilitate the identification of candidate genes and pathways responsible for NAFL/NASH transition and lead to a better understanding of NAFLD pathogenesis. The identified modules and hub genes may point to potential targets for therapeutic interventions.
引用
收藏
页码:1793 / 1804
页数:11
相关论文
共 50 条
  • [21] Nonalcoholic Fatty Liver Disease
    Isaacs, Scott
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (01) : 149 - 164
  • [22] Nonalcoholic Fatty Liver Disease
    Xia, Mao-Li
    Wang, Hai
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (03): : 294 - 295
  • [23] Nonalcoholic Fatty Liver Disease
    Paredes, Angelo H.
    Torres, Dawn M.
    Harrison, Stephen A.
    CLINICS IN LIVER DISEASE, 2012, 16 (02) : 397 - +
  • [24] Nonalcoholic fatty liver disease
    Lall, Chandana G.
    Aisen, Alex M.
    Bansal, Navin
    Sandrasegaran, Kumaresan
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 190 (04) : 993 - 1002
  • [25] Nonalcoholic fatty liver disease
    Adams, LA
    Angulo, P
    Lindor, KD
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (07) : 899 - 905
  • [26] Nonalcoholic Fatty Liver Disease After Liver Transplantation for Cryptogenic Cirrhosis or Nonalcoholic Fatty Liver Disease
    Yalamanchili, Kanthi
    Saadeh, Sherif
    Klintmalm, Goeran B.
    Jennings, Linda W.
    Davis, Gary L.
    LIVER TRANSPLANTATION, 2010, 16 (04) : 431 - 439
  • [27] Nonalcoholic Fatty Liver Disease
    Fusillo, Steven
    Rudolph, Bryan
    PEDIATRICS IN REVIEW, 2015, 36 (05) : 198 - 206
  • [28] Nonalcoholic fatty liver disease
    Erickson, Sandra K.
    JOURNAL OF LIPID RESEARCH, 2009, 50 : S412 - S416
  • [29] Nonalcoholic fatty liver disease
    Krawczyk, Marcin
    Bonfrate, Leonilde
    Portincasa, Piero
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2010, 24 (05) : 695 - 708
  • [30] Nonalcoholic fatty liver disease
    Adams, Leon A.
    Lindor, Keith D.
    ANNALS OF EPIDEMIOLOGY, 2007, 17 (11) : 863 - 869